Lincoln National Corp Ocuphire Pharma, Inc. Transaction History

Lincoln National Corp

  • $3.11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024
BUY
$1.89 - $3.27 $378 - $654
200 Added 1.71%
11,900 $23,000
Q2 2023

Aug 04, 2023
BUY
$3.63 - $6.38 $363 - $638
100 Added 0.86%
11,700 $50,000
Q4 2022

Feb 07, 2023
BUY
$2.04 - $3.53 $23,664 - $40,948
11,600 New
11,600 $40,000

Others Institutions Holding OCUP

# of Institutions
43
Shares Held
2.58M
Call Options Held
14.1K
Put Options Held
800
View Full List

About Ocuphire Pharma, Inc.

OCUP Quotes by TradingView
  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email